,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu']
asco22: enhertu aces key her2-low test in breast cancer 
Healthcare Industry Commercial Advisor | Analytics Driven Business Insights | Cyclist